三生国健药业（上海）股份有限公司股东减持股份计划公告

Group 1 - The core point of the announcement is that Dajia International plans to reduce its holdings in Sangfor Health (Shanghai) Co., Ltd. by up to 6,167,857 shares, which is 1.00% of the total share capital, due to its own funding needs [3][12]. - As of the announcement date, Dajia International holds 25,160,657 shares, representing 4.08% of the company's total share capital, which were acquired before the company's initial public offering [2][10]. - The reduction plan will take place within three months after the announcement, starting 15 trading days later, and the number of shares to be reduced will be adjusted in case of any changes in the company's share structure [3][12]. Group 2 - Dajia International has not reduced its holdings since the company went public [5]. - The shareholder has made commitments regarding the lock-up period and reduction conditions, ensuring compliance with relevant laws and regulations [7][8]. - The reduction plan is consistent with previously disclosed commitments and will not lead to a change in the company's controlling shareholder or actual controller [11][12].